• IP addresses are NOT logged in this forum so there's no point asking. Please note that this forum is full of homophobes, racists, lunatics, schizophrenics & absolute nut jobs with a smattering of geniuses, Chinese chauvinists, Moderate Muslims and last but not least a couple of "know-it-alls" constantly sprouting their dubious wisdom. If you believe that content generated by unsavory characters might cause you offense PLEASE LEAVE NOW! Sammyboy Admin and Staff are not responsible for your hurt feelings should you choose to read any of the content here.

    The OTHER forum is HERE so please stop asking.

SG is fucked. Potentially another 323,000 cases of covid-19

LITTLEREDDOT

Alfrescian (Inf)
Asset
Milllions of dollars spent testing all 323,000 dorm workers will not prevent new cases and a second wave of infection.

Two Chinese patients test positive months after coronavirus recovery
A woman walks next to the still-closed Huanan Seafood Wholesale Market in Wuhan on Aug 4, 2020.

A woman walks next to the still-closed Huanan Seafood Wholesale Market in Wuhan on Aug 4, 2020.PHOTO: AFP


BEIJING (BLOOMBERG) - Two patients in China that recovered from Covid-19 months ago tested positive for the coronavirus again, raising concern of the virus's ability to linger and reactivate in people who it previously infected.

A 68-year-old woman in the central Chinese province of Hubei, where the novel coronavirus first surfaced in December, tested positive on Sunday (Aug 9), six months after she was diagnosed with Covid-19 and recovered.

Another man found to have contracted the disease in April after returning from abroad tested positive in Shanghai on Monday but hasn't shown any symptoms.
None of the patients' close contacts has tested positive for the virus, but they have been placed under quarantine, local authorities said.

The two cases are the latest addition to a growing number of "virus reactivation" anecdotes found among patients believed to have recovered from the viral infection, which has sickened more than 20 million worldwide and killed 748,000.

While it is rare for recovered patients to test positive again, the phenomenon raises questions over why some patients suffer from long-term symptoms, and whether any immunity to the disease might be too ephemeral to protect against re-infection.

Some studies have shown the level of protective antibodies an infected person may build up to fight the virus quickly drop after only a few months, possibly making them susceptible to the same pathogen a second time.

However, there is little evidence so far that re-infection has been occurring in this pandemic.

Some experts have raised the possibility that other cells continue to provide immunity even after antibodies fade.

Researchers in South Korea have suggested that the virus detected in patients months after recovery could be the vestiges of dead virus particles that are no longer infectious.
 

sweetiepie

Alfrescian
Loyal
no way to fight
just letboss is correct
those that will die have to die
otherwise,lockdown will kill everyone
KNN if there is no way to fight my uncle think human should revise human average lifespan and many life objectives should be fine tuned KNN in other words it no nonger make sense to work for leetirement especially to ripe old age KNN
 

Hypocrite-The

Alfrescian
Loyal
If everyone uses this, then nobody will buy those expensive drugs liao.
'Screaming in their sleep like they're being murdered': Ex-soldiers sound alarm on potential COVID-19 drug
Close up of middle-aged man looking concerned, wearing red t-shirt.
Glen Norton blames the anti-malaria drug he was given in the military for his health issues.(ABC Far North: Marian Faa)
Share
Australian Army veterans given a controversial drug while deployed in East Timor have raised concerns about its safety, saying the medicine should not be used as a treatment for COVID-19.
Key points:
  • An anti-malaria drug has shown early signs as a potential treatment for COVID-19 in laboratory studies
  • Army veterans given the drug 20 years ago say it caused them long-term psychiatric side effects
  • A Senate inquiry found there was no compelling evidence of lasting health problems but experts recommend more research
The anti-malarial tafenoquine is being explored as a treatment for coronavirus with laboratory studies conducted in Melbourne claiming tafenoquine was four times more potent against SARS-CoV-2 cells than hydroxychloroquine.
The study has not yet been peer-reviewed but drug company 60 Degrees Pharmaceuticals (60P) is planning to conduct clinical research to determine its effectiveness in humans.
Chief executive Geoff Dow said the company was optimistic about the initiative.
Young smiling solider surrounded by group of local children in East Timor, looking happy.
Glen Norton says he was a "happy and keen" young soldier before taking a controversial anti-malaria drug.(ABC: Supplied)
"Like many companies, 60P and its partners are trying to do our part to provide solutions for treating and preventing COVID 19," he said.
But some doctors and veterans have raised serious concerns about tafenoquine's safety.
Glen Norton is one of almost 700 soldiers who took the anti-malarial during trials conducted by the Defence Force between 1998 and 2002.
Two decades later, Mr Norton continues to suffer chronic depression, anxiety, nightmares, hallucinations, memory loss and extreme mood swings.
He has been diagnosed with post-traumatic stress disorder but believes his symptoms are long-term side effects from taking tafenoquine.
"This drug has totally destroyed my personal life."
'We were having nightmares'
Mr Norton said he first began noticing changes when he took tafenoquine while deployed in East Timor in 2000.
"We used to call Sunday nights psycho night because of the side effects," he said.
Mr Norton is no longer in the Army and owns businesses in Cairns and Darwin.
He said he was horrified to hear tafenoquine was being considered as a treatment for coronavirus.
"I would prefer to catch COVID-19 and take the risk than to let anyone go through the pain and suffering myself and other soldiers have experienced."
Doctors debate drug's safety
Tafenoquine was approved by the Therapeutic Goods Administration for use as a malaria prevention drug in 2018.
Side effects listed in the product information include sleep disturbances, depression and anxiety in up to 1 per cent of cases.
Dr Dow said clinical studies of tafenoquine had been reviewed by independent medical experts, who concluded the drug was safe.
But some doctors have warned the drug's long-term risks may not be fully understood.
American epidemiologist Remington Nevin said tafenoquine belonged to a class of anti-malaria medications shown to be neurotoxic.
"I am afraid we're seeing the same thing potentially playing out with tafenoquine," Dr Nevin said.
"Our group's concern is that there is simply incomplete study data on these drugs."
Hydroxychloroquine tablets are displayed on a dark surface
Tafenoquine belongs to the same family of drugs as hydroxychloroquine, also developed to treat malaria.(AP: John Locher)
Dr Nevin believes there were critical flaws in the study conducted on Australian soldiers, who were deployed on peacekeeping missions at the time.
"When symptoms develop in this environment, it's very tempting to attribute these — and possibly misattribute these — simply to the stresses of deployment and not to the drugs," he said.
Others have argued the drug is safe.
University of Queensland anti-malaria expert James McCarthy gave evidence to a Senate inquiry into the use of tafenoquine in the Defence Force in 2018.
Professor McCarthy told the inquiry tafenoquine had never been associated with neuropsychiatric side effects at normal doses for preventing malaria.
"Comprehensive reviews of multiple clinical trials suggest that the incidence of neurological side effects was no higher in those receiving tafenoquine compared with a placebo," he said.
Large-scale study underway
A 2018 review by the US Food and Drug Administration found there was enough evidence to conclude tafenoquine was safe.
However, it also flagged concerns about the drug's potential neuropsychiatric side effects and recommended further research.
Some members of the review committee said safety data from clinical studies were small and the noted follow-up periods were short.
A scientist looks into a microscope while wearing a protective suit at the CSIRO Australia Animal Health Laboratory.
Researchers are looking into tafenoquine as a COVID-19 treatment.(Supplied: CSIRO)
Dr Dow said a large-scale study into the psychiatric safety of tafenoquine had been underway since 2017, with results expected in the second half of next year.
Mr Norton said clinical trials of tafenoquine against COVID-19 should not take place until further research was completed.
"How can you conduct a trial and say that this drug is safe, it's all singing, it's all dancing, when you're not looking at the long-term effects of what these drugs do to the human body?" he said.
'Some days I would have killed someone'
Veterans are calling for a royal commission into drug trials conducted by the military's Malaria and Infectious Diseases Institute, amid allegations of corruption and ethics breaches.
Wayne Karakyriacos, who also took tafenoquine while deployed in East Timor, said soldiers did not give informed consent to participate in the trials.
"We got told if you did not sign the paperwork, you would not deploy," he said.
The 2018 Senate inquiry heard evidence from more than a dozen soldiers, veterans and their relatives who said tafenoquine had a major detrimental impact on their lives.
A Defence spokeswoman said the inquiry found the trials were conducted ethically and lawfully, in keeping with national guidelines.
She said the Commonwealth had committed $2.1 million to support veterans concerned about having taken tafenoquine and other anti-malaria drugs.
"These health assessments will be conducted by GPs trained to address medical issues specific to veterans and anti-malarial medications."
The spokeswoman said Defence had agreed to 12 of the inquiry's 14 recommendations and agreed in principle to the remaining two.
Posted Yesterday, updated Yesterday
Share
 

batman1

Alfrescian
Loyal
The 4G leaders do not know how to handle the covid-19 pandemic. It's time to activate the BGs into action.
 

Hypocrite-The

Alfrescian
Loyal



PragerU


2.72M subscribers


SUBSCRIBE
"I'm angry because...people are dying because of the left...[and] doctors who have decided to politicize science." The overwhelmingly coordinated suppression of doctors speaking about treatment options for COVID-19 should terrify everyone who values free speech and the freedom to make their own health choices.
 

Leongsam

High Order Twit / Low SES subject
Admin
Asset
I've taken hydroxychloroquine with no side effects whatsoever.

However a single dose of ampicillin almost killed me.

Every drug has its risks but as long as it saves more people than it kills it is doing the job of reducing deaths and relieving symptoms.
 

Hypocrite-The

Alfrescian
Loyal
The over reaction to the virus just proves that there are powers that be are using this virus to support big pharma, and of course gahmens have got additional powers to control peoples lives. The media hypes it up as it creates news etc,,,so in the end,,,all these interest groups with their snouts and trotters in the gravy train
 
Top